Method for treating vascular disease
Patent 4968719 Issued on November 6, 1990. Estimated Expiration Date: 
April 3, 2009. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
April 3, 2009. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesPharmaceutical composition for improving the biochemical and behavioral parameters of senility Patent #: 4474812 InventorApplicationNo. 331737 filed on 04/03/1989US Classes:514/556, Inner quaternary ammonium salt (e.g., betaine, etc.)514/824ARTERIOSCLEROSISExaminersPrimary: Robinson, Allen J.Attorney, Agent or FirmInternational ClassA61K 031/205AbstractL-carnitine is effective for the treatment of peripheral vascular diseases, such as intermittent claudication. Administration of L-carnitine to patients suffering from intermittent claudication results in a significant increase in the distance the patients can walk before experiencing claudication.Other References
| |
